II. Preparations: Cryoprecipitate

  1. Derived from thawing Fresh Frozen Plasma and collecting precipitate
  2. Contains 50 ml/unit
    1. Contains high concentrations of Fibrinogen
    2. Contains high concentrations of Factor VIII
    3. Also contains Factors V, XIII, vWF

III. Indications: Adults

  1. Post-cardiac surgery Hemorrhage (or other postoperative bleeding)
  2. Massive Hemorrhage or transfusion
  3. Hypofibrinogenemia (Fibrinogen <100-150 mg/dl)

IV. Indications: Newborns

  1. Factor VIII Deficiency (if recombinant factor VIII not available)
  2. Von Willebrand Disease (if recombinant factors not available)
  3. Factor XIII deficiency
  4. Congenital Dysfibrinogenemia
  5. Congenital Fibrinogen deficiency

V. Labs: Fibrinogen

  1. Increases Fibrinogen up to 100 mg/dl per dose (15-20 ml per 5-7 kg body weight, or 10 units for 70 kg)
  2. Expect one unit to raise Fibrinogen 5-10 mg/dl
  3. Goal Fibrinogen >100 mg/dl

VI. Dosing

  1. Adults: 15-20 ml per 5-7 kg body weight
    1. Typical dose: 10 units Cryoprecipitate
  2. Newborn: variable dosing starting from 2 ml/kg

VII. Adverse Effects

Images: Related links to external sites (from Bing)

Related Studies

Ontology: Cryoprecipitate (C0443121)

Concepts Pharmacologic Substance (T121)
SnomedCT 420599006, 256401009
LNC LP14585-1
English Cryoprecipitate (substance), cryoprecipitates, cryoprecipitate, cryoprecipitated, Cryoprecipitate, Cryoprecipitate (product), Cryoprecipitate (qualifier value)
Spanish crioprecipitado (sustancia), crioprecipitado (calificador), crioprecipitado, crioprecipitado (producto)